{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 681,
  "pageSize": 18,
  "pageCount": 17777,
  "rows": [
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 18,
      "slideType": "market_landscape",
      "function": "frame_problem",
      "notes": "The slide highlights the 'me-too' drug development problem in China.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/18",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-18",
      "loopMatches": [
        {
          "to": 20,
          "from": 11,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "90bfd894-313f-433e-b1a3-d0f790c2452f",
          "evidence": "The report highlights the challenges facing China's clinical development, including homogeneous competition and a need for more innovative and differentiated therapies.",
          "position": 0,
          "objective": "What are the consequences of not pivoting to high-quality growth in China's clinical trials?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "b805e1f5-4eeb-45d7-a58b-7531d46e8580",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "The report proposes a solution, focusing on strategic trends such as development of more innovative and differentiated therapies.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 19,
      "slideType": "industry_trends",
      "function": "establish_context",
      "notes": "The slide uses a dual-column layout to contrast market drivers (left) with specific regulatory examples (right).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/19",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-19",
      "loopMatches": [
        {
          "to": 20,
          "from": 11,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "90bfd894-313f-433e-b1a3-d0f790c2452f",
          "evidence": "The report highlights the challenges facing China's clinical development, including homogeneous competition and a need for more innovative and differentiated therapies.",
          "position": 0,
          "objective": "What are the consequences of not pivoting to high-quality growth in China's clinical trials?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "b805e1f5-4eeb-45d7-a58b-7531d46e8580",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "The report proposes a solution, focusing on strategic trends such as development of more innovative and differentiated therapies.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 20,
      "slideType": "industry_trends",
      "function": "summarize",
      "notes": "The slide uses a stacked bar chart to show survey responses and a callout box for qualitative expert feedback.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/20",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-20",
      "loopMatches": [
        {
          "to": 20,
          "from": 11,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "90bfd894-313f-433e-b1a3-d0f790c2452f",
          "evidence": "The report highlights the challenges facing China's clinical development, including homogeneous competition and a need for more innovative and differentiated therapies.",
          "position": 0,
          "objective": "What are the consequences of not pivoting to high-quality growth in China's clinical trials?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "b805e1f5-4eeb-45d7-a58b-7531d46e8580",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Solution & Approach",
          "beatSlug": "consultants-gambit-solution-approach",
          "evidence": "The report proposes a solution, focusing on strategic trends such as development of more innovative and differentiated therapies.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 21,
      "slideType": "industry_trends",
      "function": "analyze_data",
      "notes": "The slide uses stacked bar charts to show clinical trial phases over time, with CAGR annotations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/21",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 22,
      "slideType": "client_example",
      "function": "illustrate_case",
      "notes": "The slide uses a three-row structure to map strategic pillars to real-world examples and qualitative expert validation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/22",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 23,
      "slideType": "agenda",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/23",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 24,
      "slideType": "industry_trends",
      "function": "analyze_data",
      "notes": "The chart shows a clear shift in clinical trial focus toward oncology, increasing from 30% in 2016 to 48% in 2022.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/24",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 25,
      "slideType": "industry_trends",
      "function": "summarize",
      "notes": "Uses a 'Past vs Future' transformation framework to illustrate strategic shift.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/25",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 26,
      "slideType": "data_table",
      "function": "analyze_data",
      "notes": "The chart highlights factors directly related to commercial attractiveness in green.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/26",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 27,
      "slideType": "market_landscape",
      "function": "analyze_data",
      "notes": "The chart uses a 7-point Likert scale. The top 4 categories are highlighted in green.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/27",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 28,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a list format with icons to categorize qualitative feedback from interviews.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/28",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 29,
      "slideType": "agenda",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/29",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 30,
      "slideType": "industry_trends",
      "function": "establish_context",
      "notes": "The slide uses a structured table to map trends to operational/technical complexity and their specific implications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/30",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 31,
      "slideType": "timeline",
      "function": "establish_context",
      "notes": "The slide uses a chronological framework to explain the shift from paper-based to integrated digital platforms in clinical trials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/31",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 32,
      "slideType": "data_table",
      "function": "analyze_data",
      "notes": "The chart combines a horizontal bar chart for penetration rates with a stakeholder usage matrix.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/32",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 33,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "Includes bilingual survey methodology notes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/33",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 34,
      "slideType": "industry_trends",
      "function": "summarize",
      "notes": "The slide uses a combination of quantitative survey data and qualitative expert quotes to validate the trend towards smart clinical trial formats.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/34",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5ca1-7489-b638-42055a53b541",
      "docSlug": "1774c324fda45105",
      "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
      "authorId": "LEK",
      "authorName": "L.E.K.",
      "documentKindSlug": "consulting-deck",
      "documentKindLabel": "Consulting deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.778,
      "pageNumber": 35,
      "slideType": "timeline",
      "function": "establish_context",
      "notes": "The slide tracks the progression of Chinese regulatory guidelines (CDE) towards patient-centric and remote clinical trial methodologies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/35",
      "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
      "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}